Gynesonics pulls in $3 million in a new debt financing that will help fuel further development of its VizAblate fibroid treatment device.
California's Gynesonics reported raising $3 million in a new debt offering as it pursues development of its VizAblate fibroid treatment device.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1d9ZvhM
Cap comentari:
Publica un comentari a l'entrada